Lucy Lu - Net Worth and Insider Trading

Lucy Lu Net Worth

The estimated net worth of Lucy Lu is at least $12,446 dollars as of 2024-04-26. Lucy Lu is the Director of Veru Inc and owns about 9,800 shares of Veru Inc (VERU) stock worth over $12,446. Details can be seen in Lucy Lu's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Lucy Lu has not made any transactions after 2021-08-17 and currently still holds the listed stock(s).

Transaction Summary of Lucy Lu

To

Lucy Lu Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Lucy Lu owns 3 companies in total, including Avenue Therapeutics Inc (ATXI) , Veru Inc (VERU) , and Fortress Biotech Inc (FBIO) .

Click here to see the complete history of Lucy Lu’s form 4 insider trades.

Insider Ownership Summary of Lucy Lu

Ticker Comapny Transaction Date Type of Owner
ATXI Avenue Therapeutics Inc 2020-02-12 director & President & CEO
VERU Veru Inc 2021-08-17 director
FBIO Fortress Biotech Inc 2022-12-14 director

Lucy Lu Latest Holdings Summary

Lucy Lu currently owns a total of 1 stock. Lucy Lu owns 9,800 shares of Veru Inc (VERU) as of August 17, 2021, with a value of $12,446.

Latest Holdings of Lucy Lu

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
VERU Veru Inc 2021-08-17 9,800 1.27 12,446

Holding Weightings of Lucy Lu


Lucy Lu Form 4 Trading Tracker

According to the SEC Form 4 filings, Lucy Lu has made a total of 1 transactions in Veru Inc (VERU) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Veru Inc is the acquisition of 4,800 shares on August 17, 2021, which cost Lucy Lu around $32,544.

Insider Trading History of Lucy Lu

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Lucy Lu Trading Performance

GuruFocus tracks the stock performance after each of Lucy Lu's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Lucy Lu is 33.47%. GuruFocus also compares Lucy Lu's trading performance to market benchmark return within the same time period. The performance of stocks bought by Lucy Lu within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Lucy Lu's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Lucy Lu

Average Return

153.95%

Average return per transaction

Outperforming Transactions

100%

2 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 27.2 33.47 5.71 153.95 -19.22 53.91
Relative Return to S&P 500(%) 26.59 29.79 2.55 148.95 -23.63 46.95

Lucy Lu Ownership Network

Ownership Network List of Lucy Lu

No Data

Ownership Network Relation of Lucy Lu


Lucy Lu Owned Company Details

What does Avenue Therapeutics Inc do?

Who are the key executives at Avenue Therapeutics Inc?

Lucy Lu is the director & President & CEO of Avenue Therapeutics Inc. Other key executives at Avenue Therapeutics Inc include 10 percent owner Fortress Biotech, Inc. , 10 percent owner Invagen Pharmaceuticals, Inc. , and Chief Executive Officer Alexandra Maclean .

Avenue Therapeutics Inc (ATXI) Insider Trades Summary

Over the past 18 months, Lucy Lu made no insider transaction in Avenue Therapeutics Inc (ATXI). Other recent insider transactions involving Avenue Therapeutics Inc (ATXI) include a net sale of 617,000 shares made by , a net purchase of 418,410 shares made by Fortress Biotech, Inc. , and a net purchase of 348,675 shares made by Rosenwald Lindsay A Md .

In summary, during the past 3 months, insiders sold 0 shares of Avenue Therapeutics Inc (ATXI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 8,227 shares of Avenue Therapeutics Inc (ATXI) were sold and 10,228 shares were bought by its insiders, resulting in a net purchase of 2,001 shares.

Avenue Therapeutics Inc (ATXI)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Avenue Therapeutics Inc Insider Transactions

No Available Data

Lucy Lu Mailing Address

Above is the net worth, insider trading, and ownership report for Lucy Lu. You might contact Lucy Lu via mailing address: The Female Health Company, 4400 Biscayne Boulevard, Suite 888, Miami Fl 33137.

Discussions on Lucy Lu

No discussions yet.